Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus

Aoyama-Maeda, Natsuki; Horino, Taro; Ichii, Osamu; Terada, Yoshio

Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus

Romanian Journal of Internal Medicine

Volume 56 (2018): Issue 2 (June 2018)

By:

Natsuki Aoyama-Maeda, Taro Horino, Osamu Ichii and Yoshio Terada

Open Access

|May 2018

References

1. HENTER JI., HORNE A., ARICÓ M., EGELER RM., FILIPOVICH AH., IMASHUKU S., et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocyticlymphohistiocytosis. Pediatr Blood Cancer. 2007; 48(2):124-31.10.1002/pbc.21039
Open DOI Search in Google Scholar Back to article
2. TAN EM., COHEN AS., FRIES JF., MASI AT., MCSHANE DJ., ROTHFIELD NF., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271-7.10.1002/art.1780251101
Search in Google Scholar Back to article
3. BODE SF., LEHMBERG K., MAUL-PAVICIC A., VRAETZ T., JANKA G., STADT UZ., et al. Recent advances in the diagnosis and treatment of hemophagocyticlymphohistiocytosis. Arthritis Res Ther. 2012; 14(3):213.10.1186/ar3843
Open DOI Search in Google Scholar Back to article
4. FUKAYA S., YASUDA S., HASHIMOTO T., OKU K., KATAOKA H., HORITA T., et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008; 47(11):1686-91.10.1093/rheumatology/ken342
Search in Google Scholar Back to article
5. EGÜES DUBUC CA., URIARTE ECENARRO M., MENESES VILLALBA C., ALDASORO CÁCERES V., HERNANDO RUBIO I., BELZUNEGUI OTANO J. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus. Reumatol Clin. 2014; 10(5):321-4.10.1016/j.reumae.2013.09.004
Search in Google Scholar Back to article
6. KUMAKURA S., MURAKAWA Y. Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol. 2014; 66(8):2297-307.10.1002/art.38672
Search in Google Scholar Back to article
7. JORDAN MB., ALLEN CE., WEITZMAN S., FILIPOVICH AH., MCCLAIN KL. How I treat hemophagocyticlym-phohistiocytosis. Blood. 2011; 118(15):4041-52.10.1182/blood-2011-03-278127
Open DOI Search in Google Scholar Back to article
8. HANNAH J., CASIAN A., D’CRUZ D. Tacrolimus use in lupus nephritis: A systematic review and meta-analysis. Autoimmun Rev. 2016; 15(1):93-101.10.1016/j.autrev.2015.09.006
Search in Google Scholar Back to article

DOI: https://doi.org/10.1515/rjim-2017-0043 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Page range: 117 - 121

Submitted on: Oct 8, 2017

Published on: May 17, 2018

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

hemophagocyticlymphohistiocytosis (HLH),

intravenous immunoglobulin (IVIG),

macrophage activation syndrome (MAS),

systemic lupus erythematosus (SLE),

Related subjects:

Internal medicine, other,

Cardiology,

Gastroenterology,

Rheumatology

© 2018 Natsuki Aoyama-Maeda, Taro Horino, Osamu Ichii, Yoshio Terada, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2018): Issue 2 (June 2018)Next article